Developing biomarkers in mood disorders research through the use of rapid-acting antidepressants.
Ontology highlight
ABSTRACT: An impediment to progress in mood disorders research is the lack of analytically valid and qualified diagnostic and treatment biomarkers. Consistent with the National Institute of Mental Health (NIMH)'s Research Domain Criteria (RDoC) initiative, the lack of diagnostic biomarkers has precluded us from moving away from a purely subjective (symptom-based) toward a more objective diagnostic system. In addition, treatment response biomarkers in mood disorders would facilitate drug development and move beyond trial-and-error toward more personalized treatments. As such, biomarkers identified early in the pathophysiological process are proximal biomarkers (target engagement), while those occurring later in the disease process are distal (disease pathway components). One strategy to achieve this
SUBMITTER: Niciu MJ
PROVIDER: S-EPMC3984598 | biostudies-literature | 2014 Apr
REPOSITORIES: biostudies-literature
ACCESS DATA